obesity in pregnancy november 14, 2009. overview general issues of obesity prevalence of obesity in...
TRANSCRIPT
Overview
General issues of obesity Prevalence of obesity in pregnant
women Effect of obesity on maternal outcome Effect of obesity on neonatal outcome Issues of clinical care
Obesity Classifications
BMI = kg/m2
Normal 18.5 – 24.9 Overweight 25-29.9 Obesity ≥ 30
Class I 30 - 34.9 Class II 35 - 39.9 Class III ≥ 40
Recent national data
Is the epidemic leveling out? Prevalence among low-income, preschool-
aged children 12.4% in 1998 to 14.5% in 2003 No further increase:14.6% prevalence in 2008.
Prevalence of adult obesity Dramatic increase1999 to 2006. No significant change between 2003-2004 and
2005-2006
How did we get here
The problem is intake more than energy expense ↑ 10% calorie intake 1985-2000 Mostly carbohydrates Mostly beverages: ~50% increase in fruit juice
and soft drinks More snacking Larger portions
Morbidity from obesity
Metabolic syndrome/insulin resistance syndrome Metabolic core obesity (central obesity)
Elevated waist/hip ratio Insulin resistance
Morbidity from obesity Hypertension Dyslipidemia (for example, high total
cholesterol or high levels of triglycerides)
Type 2 diabetes Coronary heart disease Stroke Gallbladder disease Osteoarthritis Sleep apnea and respiratory problems Some cancers (endometrial, breast,
and colon) Nonalcoholic steatohepatitis (NASH) 50 to 100% increase in premature
deaths from all causes
Pathophysiology of obesity
Cardiac effects Increased oxygen demand, blood
volume, cardiac output, hypertension Longstanding obesity: decreased
diastolic interval and time for myocardial perfusion, diastolic dysfunction
Insulin resistance Diabetes
Direct Arthritis Sleep apnea
Estrogen Endometrial and breast CA
Respiratory pathophysiology
Sleep apnea (snoring, apnea, daytime somnolence
Airway obstruction Rapid desaturation with apnea (↓FRC) Difficulty with ventilation
Infertility/miscarriage
High prevalence of PCOS Negative impact on infertility treatment Miscarriage after infertility Rx
OR 1.77 OI with gonadotropins OR 3 Egg donor cycle OR 4
Miscarriage OR 1.2
Recurrent SAb 3.5
Adverse outcomes associated with obesity in pregnancy
fetal structural abnormalities gestational diabetes macrosomia and childhood obesity preeclampsia/hypertension urinary tract infection thromboembolism perinatal death postdates pregnancy induction of labor cesarean section wound infection postpartum hemorrhage
Metabolic syndrome-like complication of late pregnancy Gestational diabetes Hypertension/preeclampsia
Maternal morbidity - insulin resistance Higher fasting and post absorptive plasma
insulin Most women achieve euglycemia Overweight status: RR of GDM 1.8 to 6.5 Obese: RR GDM 1.4 to 20 Need early diagnosis of diabetes
Maternal morbidity - hypertension
Higher BP: hemoconcentration, altered cardiac function
Even moderate obesity increases risk of HTN/PIH
Obese: RR HTN 2.2 to 21.4 RR Preeclampsia 1.22 to 9.7 Risk of pre-eclampsia doubles with each 5 to
7 kg/m2 increase in pre-pregnancy BMI
Maternal morbidity - hypertension/preeclampsia Diabetes has additional effect
Good control helps Preeclampsia risk
Obese women with well controlled GDM 10% Average weight with well controlled GDM 8% Obese women with poorly controlled GDM 15%
Macrosomia
Weiss, et al. >4000 grams
8.3% normal weight 13.3% obese 14.6% morbidly obese
Correlation with weight gain, pregravid weight
Fetus of obese women-hyperinsulinemia
Obese women- increase glucose, triglycerides and amino acid turnover
Fetal death
Cedergren 2004 n=~300,00 OR 3 for obese v normal
Kristensen 2005 n= ~25,000 OR for fetal death 2.8 OR for neonatal death 2.6
Meta-analysis Chu, et al. 2007 Overweight v normal OR 1.47 Obese v normal OR 2.07
Fetal death
Partially attributed to co-morbidities. Not completely explained
Increase placental histopathologic abnormality
Maternal death
18% of obstetric causes of maternal death are associated with obesity
80% of anesthesia deaths are associated with obesity
UK Maternal mortality 2000-2002 35% or maternal deaths had obesity
compared with 23% of general population
Maternal long term complications
Urinary stress and urge incontinence
Weight gains correlate with weight retention and worsening obesity
In 15 year follow up after GDM 70% of obese women have type 2
DM 30% of lean women have type 2 DM
Long term weight development after pregnancies
Wide variation in weight loss/gain. Average is 0.5 kg one year postpartum
Very difficult to tease out the factors Most important factor for sustained weight
gain is gain during pregnancy Not predictive: pre pregnancy wt., parity,
socioeconomics, occupation, marital status, dietary advise
Effect of lactation is small
Longterm neonatal impact
Increased risk of infant, childhood and adult obesity
Increased risk of metabolic syndrome in adolescence
Maternal BMI and diabetes account for most of this relationship
Obesity and diabetes likely to be independent risk factors
Much greater impact than IUGR
Bariatric surgery
Malabsorptive Jejeunoileal bypass Pancreaticobiliary diversion
Restrictive Gastric banding Vertical gastric gastropathy
Bariatric surgery
Initial worrisome case reports regarding pregnancy outcome: neonatal nutrition deficiency, IUGR, fetal death
More recent data are reassuring Recommendations give to delay pregnancy for 18
months. Advise patients of increased fertility. Nutrient deficiencies: B12, folate, Fe, Ca, Zinc Monitor nutrients and weight Explain increased calorie, protein and nutrient
demands
Gastric banding
Requires deflation if severe nausea and vomiting
May be increased rate of band complications (migration or leaking)
Recommendation given to wait 12-18 months. Explain improved fertility with weight loss
Nutrient deficiencies still possible: B12, folate, Fe, Ca, Zinc
Monitor nutrients and weight
Psychosocial issues
Depression Poor self-esteem Social discrimination Family support/lack of support for self-care
and weight loss
Preconception care
Assess co morbidity Formal diabetes screen Healthy life style coaching Consider bariatric surgery referral Counseling
Maternal risks Fetal risks Delivery: access to timely c/s, risks of c/s and
fetal monitoring issues
Prenatal considerations
Identification of patients BMI measurements in clinic Keep track of weight gain
Consider early dating ultrasound New OB labs include baseline 24 hour
urine, creatinine, AST (PIH and NASH)
Early glucose challenge!!
Prenatal considerations
Consider cardiology evalulation or echocardiogram BMI >35 and comorbidity Longstanding class III obesity
Dietician consultation Counseling about exercise Anesthesiology Consultation Sleep medicine prn Review birth control plans
Optimal weight gain
Most studies do not show correlation of low weight gain and low birth weight in obese women
High weight gains do lead to macrosomia
Lower weight gain - less retention
IOM guideline 2009
Prepregancy BMI TWG lb Rates of gain 2nd and 3rd trimester
Underweight
<18.5 28–40
1 lb/wk
(1–1.3)
Normal weight
18.5-24.9 25–35
1 lb/wk
(0.8–1)
Overweight
25.0-29.9 15–25
0.6 lb/wk
(0.5–0.7)
Obese
≥30.0 11–20
0.5 lb/wk
(0.4–0.6)
IOM 2009
Provisional guidelines for weight gain for twin pregnancies Normal BMI: 37-54 pounds Overweight: 31-50 pounds Obese women: 25-42 pounds
Surveillance during pregnancy
Growth ultrasound Frequent visits- surveillance for hypertension Fetal kick counts Antenatal testing not yet indicated 12
Contraception
Combined OC Venous and arterial thromboembolism risk Increased failure rate especially very low dose Combined OC: extra 2-4 pregnancies/woman-years Royal College of OB GYN
Risks generally outweigh benefits with BMI 35-39 Contraindicated BMI > 40
Patch: Package insert: Lower effectiveness if weight > 90 kg
No data: ring, implants, plan B Implanon: lower serum etonogestrel levels DMPS – weight gain, as effective as normal BMI